ITGB2 and neoplasm: Of interest, the few cell conjugates forming among IL-33 EO and tumor cells in the presence of anti-CD18 blocking mAb did not show increased ICAM-1 polarization (Figure S11), suggesting that ICAM-1 does not compensate for lack of CD11b/CD18-mediated adhesion.